Following on from our hugely successful pharmaceutical microbiology conference in 2011 SMi will provide a global forum for senior level decision makers and those working within microbiology fields to meet.
Pharmaceutical Microbiology 2013 aims to concentrate on recent developments in lab design, new latest trends in sterility & decontamination and demonstrations of new technologies such as advances in rapid microbial methods.
Our two-day conference will provide useful insights into the latest developments within Pharmaceutical Microbiology. With an international array of speakers, enhance your product launches or your own new developments with key decision makers from big pharma, biotech and academia.
Microbial contamination of products and processes in a lab and manufacturing environment continues to pose a major problem to the Pharmaceutical and Biotechnological industries and its regulators. Attendees will be presented with a series of case studies of recent developments along with practical methods and examples of how to effectively manage your sterile environment.
- The latest tools, techniques, and procedures used in the identification and control of contaminants
- Sterile production and handling of traditional drugs and biologics
- Design, construction, and validation of sterile facilities and equipment
- New Rapid Microbial Methods to test and detect for the presence of contaminants
Microbiologists
Biological manufacture and production
Quality Control and Quality Assurance
Antimicrobial and biocide research
|
Biotech Research and Development
Sterile lab management
Validation and Regulatory affairs
Sterile facilities design and construction
|
Alfa Wassermann BV; Astrazeneca; Barts and The London NHS Trust; Becton Dickinson Gmb H; Bio Products Laboratory; BioMerieux; Blenkharn Environmental; Bovis Lend Lease Pharmaceuticals; Celsis; Celsis Ltd; Genentech; Genzyme ; Glaxochem Ltd; GlaxoSmithKline; Johnson & Johnson; Med Pharma Service; MedImmune; Merck Millipore; MHRA; Ministry of Health; Moorfields Pharmaceuticals; Novo Nordisk A/S; Patheon Italia SpA; Patheon UK Ltd; Pfizer; Qualitest Pharmaceuticals, Inc.; Reckitt Benckiser Healthcare; Sanofi-Aventis Ltd Dagenham; schering Plough; STERIS Corporation; University Of Cambridge; Wickham Laboratories Ltd;